{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:21:47Z","timestamp":1792099307939,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T00:00:00Z","timestamp":1486166400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Legal Med"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00414-017-1541-6","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T21:43:52Z","timestamp":1486158232000},"page":"979-988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer"],"prefix":"10.1007","volume":"131","author":[{"given":"Souleiman","family":"El Balkhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Chaslot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Dulaurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Delage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Saint-Marcoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,4]]},"reference":[{"key":"1541_CR1","unstructured":"UNODC 2014. World_Drug_Report_2014. World Drug Report United Nations publication Sales No. E.14.XI.7. \nhttps:\/\/www.unodc.org\/documents\/data-and-analysis\/WDR2014\/World_Drug_Report_2014_web.pdf\n\n. Accessed 12 Sep 2016"},{"key":"1541_CR2","unstructured":"New psychoactive substances in Europe.(2015) An update from the EU Early Warning System | \nwww.emcdda.europa.eu\n\n. http:\/\/\nwww.emcdda.europa.eu\n\n\/publications\/2015\/new-psychoactive-substances. Accessed 13 Sep 2016"},{"key":"1541_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/jat\/bkv079","volume":"39","author":"JL Poklis","year":"2015","unstructured":"Poklis JL, Dempsey SK, Liu K et al (2015) Identification of metabolite biomarkers of the designer hallucinogen 25I-NBOMe in mouse hepatic microsomal preparations and human urine samples associated with clinical intoxication. J Anal Toxicol 39:607\u2013616. doi:\n10.1093\/jat\/bkv079","journal-title":"J Anal Toxicol"},{"key":"1541_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00414-015-1279-y","volume":"130","author":"ML Warner","year":"2016","unstructured":"Warner ML, Kaufman NC, Grundmann O (2016) The pharmacology and toxicology of kratom: from traditional herb to drug of abuse. Int J Legal Med 130:127\u2013138. doi:\n10.1007\/s00414-015-1279-y","journal-title":"Int J Legal Med"},{"key":"1541_CR5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jat\/33.8.491","volume":"33","author":"M Forsman","year":"2009","unstructured":"Forsman M, Nystr\u00f6m I, Roman M et al (2009) Urinary detection times and excretion patterns of flunitrazepam and its metabolites after a single oral dose. J Anal Toxicol 33:491\u2013501","journal-title":"J Anal Toxicol"},{"key":"1541_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00414-008-0291-x","volume":"123","author":"S Djezzar","year":"2009","unstructured":"Djezzar S, Questel F, Burin E et al (2009) Chemical submission: results of 4-year French inquiry. Int J Legal Med 123:213\u2013219. doi:\n10.1007\/s00414-008-0291-x","journal-title":"Int J Legal Med"},{"key":"1541_CR7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/wps.20236","volume":"14","author":"B Moosmann","year":"2015","unstructured":"Moosmann B, King LA, Auw\u00e4rter V (2015) Designer benzodiazepines: a new challenge. World Psychiatry Off J World Psychiatr Assoc WPA 14:248. doi:\n10.1002\/wps.20236","journal-title":"World Psychiatry Off J World Psychiatr Assoc WPA"},{"key":"1541_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11419-015-0277-6","volume":"33","author":"LM Huppertz","year":"2015","unstructured":"Huppertz LM, Bisel P, Westphal F et al (2015) Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites. Forensic Toxicol 33:388\u2013395. doi:\n10.1007\/s11419-015-0277-6","journal-title":"Forensic Toxicol"},{"key":"1541_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jchromb.2016.08.047","volume":"1035","author":"M Pettersson Bergstrand","year":"2016","unstructured":"Pettersson Bergstrand M, Helander A, Beck O (2016) Development and application of a multi-component LC\u2013MS\/MS method for determination of designer benzodiazepines in urine. J Chromatogr B 1035:104\u2013110. doi:\n10.1016\/j.jchromb.2016.08.047","journal-title":"J Chromatogr B"},{"key":"1541_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2003","author":"M Pettersson Bergstrand","year":"2016","unstructured":"Pettersson Bergstrand M, Helander A, Hansson T, Beck O (2016) Detectability of designer benzodiazepines in CEDIA, EMIT II plus, HEIA, and KIMS II immunochemical screening assays. Drug Test Anal n\/a-n\/a. doi:\n10.1002\/dta.2003","journal-title":"Drug Test Anal n\/a-n\/a"},{"key":"1541_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11419-013-0187-4","volume":"31","author":"B Moosmann","year":"2013","unstructured":"Moosmann B, Hutter M, Huppertz LM et al (2013) Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine. Forensic Toxicol 31:263\u2013271. doi:\n10.1007\/s11419-013-0187-4","journal-title":"Forensic Toxicol"},{"key":"1541_CR12","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jms.3279","volume":"48","author":"B Moosmann","year":"2013","unstructured":"Moosmann B, Huppertz LM, Hutter M et al (2013) Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics. J Mass Spectrom JMS 48:1150\u20131159. doi:\n10.1002\/jms.3279","journal-title":"J Mass Spectrom JMS"},{"key":"1541_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/dta.1628","volume":"6","author":"B Moosmann","year":"2014","unstructured":"Moosmann B, Bisel P, Auw\u00e4rter V (2014) Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics. Drug Test Anal 6:757\u2013763. doi:\n10.1002\/dta.1628","journal-title":"Drug Test Anal"},{"key":"1541_CR14","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1007\/s00216-016-9439-6","volume":"408","author":"MR Meyer","year":"2016","unstructured":"Meyer MR, Bergstrand MP, Helander A, Beck O (2016) Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes. Anal Bioanal Chem 408:3571\u20133591. doi:\n10.1007\/s00216-016-9439-6","journal-title":"Anal Bioanal Chem"},{"key":"1541_CR15","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1373\/clinchem.2005.065631","volume":"52","author":"O Quintela","year":"2006","unstructured":"Quintela O, Sauvage F-L, Charvier F et al (2006) Liquid chromatography\u2013tandem mass spectrometry for detection of low concentrations of 21 benzodiazepines, metabolites, and analogs in urine: method with forensic applications. Clin Chem 52:1346\u20131355. doi:\n10.1373\/clinchem.2005.065631","journal-title":"Clin Chem"},{"key":"1541_CR16","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1002\/jssc.200900092","volume":"32","author":"F-L Sauvage","year":"2009","unstructured":"Sauvage F-L, Picard N, Saint-Marcoux F et al (2009) General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: applications and constraints. J Sep Sci 32:3074\u20133083. doi:\n10.1002\/jssc.200900092","journal-title":"J Sep Sci"},{"key":"1541_CR17","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1373\/clinchem.2006.067116","volume":"52","author":"F-L Sauvage","year":"2006","unstructured":"Sauvage F-L, Saint-Marcoux F, Duretz B et al (2006) Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry. Clin Chem 52:1735\u20131742. doi:\n10.1373\/clinchem.2006.067116","journal-title":"Clin Chem"},{"key":"1541_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S1044-0305(02)00801-2","volume":"14","author":"F Saint-Marcoux","year":"2003","unstructured":"Saint-Marcoux F, Lach\u00e2tre G, Marquet P (2003) Evaluation of an improved general unknown screening procedure using liquid chromatography-electrospray-mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography\u2014diode array detection. J Am Soc Mass Spectrom 14:14\u201322. doi:\n10.1016\/S1044-0305(02)00801-2","journal-title":"J Am Soc Mass Spectrom"},{"key":"1541_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.forsciint.2008.08.012","volume":"182","author":"T Nakamae","year":"2008","unstructured":"Nakamae T, Shinozuka T, Sasaki C et al (2008) Case report: etizolam and its major metabolites in two unnatural death cases. Forensic Sci Int 182:e1\u2013e6. doi:\n10.1016\/j.forsciint.2008.08.012","journal-title":"Forensic Sci Int"},{"key":"1541_CR20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1520\/JFS14827J","volume":"45","author":"A Negrusz","year":"2000","unstructured":"Negrusz A, Moore CM, Stockham TL et al (2000) Elimination of 7-aminoflunitrazepam and flunitrazepam in urine after a single dose of Rohypnol. J Forensic Sci 45:1031\u20131040","journal-title":"J Forensic Sci"},{"key":"1541_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","volume":"125","author":"JD Jones","year":"2012","unstructured":"Jones JD, Mogali S, Comer SD (2012) Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend 125:8\u201318. doi:\n10.1016\/j.drugalcdep.2012.07.004","journal-title":"Drug Alcohol Depend"},{"key":"1541_CR22","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1002\/rcm.4207","volume":"23","author":"AC Li","year":"2009","unstructured":"Li AC, Ding J, Jiang X, Denissen J (2009) Two-injection workflow for a liquid chromatography\/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification. Rapid Commun Mass Spectrom RCM 23:3003\u20133012. doi:\n10.1002\/rcm.4207","journal-title":"Rapid Commun Mass Spectrom RCM"},{"key":"1541_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jms.3840","author":"B Moosmann","year":"2016","unstructured":"Moosmann B, Bisel P, Franz F et al (2016) Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines\u2014an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam, and nitrazolam. J Mass Spectrom JMS. doi:\n10.1002\/jms.3840","journal-title":"J Mass Spectrom JMS"}],"container-title":["International Journal of Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00414-017-1541-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-017-1541-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-017-1541-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T03:40:05Z","timestamp":1498707605000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00414-017-1541-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1541"],"URL":"https:\/\/doi.org\/10.1007\/s00414-017-1541-6","relation":{},"ISSN":["0937-9827","1437-1596"],"issn-type":[{"value":"0937-9827","type":"print"},{"value":"1437-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,4]]}}}